Principle Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Principle Wealth Partners's NVO Position: Q3 2026 in Review
Principle Wealth Partners increased its Novo Nordisk (NVO) stake by 21% in Q3 2026, buying an estimated $100K and bringing the position to 12,663 shares worth $480K. The position accounts for 0.02% of the portfolio, ranked #266.
Principle Wealth Partners first reported a position in NVO in Q2 2020 and has held it in 13 quarters since. The position peaked at $729K in Q3 2025. 1,223 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Principle Wealth Partners held 12,663 shares of Novo Nordisk worth $480K as of Q3 2026.
- Principle Wealth Partners bought 2,166 Novo Nordisk shares in Q3 2026, an estimated $100K.
- Novo Nordisk made up 0.02% of Principle Wealth Partners's portfolio in Q3 2026, its #266 holding.
- Principle Wealth Partners first reported a position in Novo Nordisk in Q2 2020 and has held it in 13 quarters since.
- Principle Wealth Partners's Novo Nordisk position peaked at $729K in Q3 2025.
- 1,223 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Principle Wealth Partners's 13F filing for Q3 2026, filed 2 Nov 2026.